HIGHLIGHTS
- What: In most cases patients showed symptom improvement; however four studies reported cases where patients either expired without symptom improvement or experienced sequelae. This approach was designed to examine uncommon adverse events in this specific context thoroughly.
- Who: Eunso Lee et al. from the Division of Allergy and Pulmonology, Department of Internal Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea have published the research: Uncommon Adverse Events of Immune Checkpoint Inhibitors in Small Cell Lung Cancer: A Systematic Review of Case Reports, in the Journal: (JOURNAL) of 31/Dec/2023
SUMMARY . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.